U.S.-UK Trade Deal Opens Door To Pharma Tariff Cuts, Pending Review

By Maaisha Osman / May 9, 2025 at 2:05 PM

The United States and the United Kingdom are laying the groundwork for a major shift in pharmaceutical trade, announcing plans Friday (May 9) to negotiate “significantly preferential” tariff treatment for medicines and ingredients as part of a deal announced this week -- though any concrete reductions will hinge on the U.S. Commerce Department’s section 232 national security investigation into pharmaceutical imports.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.

FEATURES

NEWSLETTERS

ABOUT US

Inside Health Policy is a subscription-fee-based daily digital news service from Inside Washington Publishers.

SITE LICENSES

Economical site license packages are available to fit any size organization, from a few people at one location to company-wide access. For more information on how you can get greater access to Inside Health Policy for your office, contact Online Customer Service at 703-416-8505 or healthpolicy@iwpnews.com.

STAY CONNECTED

U.S.-UK Trade Deal Opens Door To Pharma Tariff Cuts, Pending Review

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.